These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16125798)

  • 1. Gene-transfer technology: a preventive neurotherapy to curb obesity, ameliorate metabolic syndrome and extend life expectancy.
    Kalra SP; Kalra PS
    Trends Pharmacol Sci; 2005 Oct; 26(10):488-95. PubMed ID: 16125798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin gene transfer in the hypothalamus enhances longevity in adult monogenic mutant mice in the absence of circulating leptin.
    Boghossian S; Ueno N; Dube MG; Kalra P; Kalra S
    Neurobiol Aging; 2007 Oct; 28(10):1594-604. PubMed ID: 17011078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of fat deposition for the life time with gene therapy.
    Boghossian S; Lecklin A; Torto R; Kalra PS; Kalra SP
    Peptides; 2005 Aug; 26(8):1512-9. PubMed ID: 16042991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity and metabolic syndrome: long-term benefits of central leptin gene therapy.
    Kalra PS; Kalra SP
    Drugs Today (Barc); 2002 Nov; 38(11):745-57. PubMed ID: 12582458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global life-long health benefits of repression of hypothalamic NPY system by central leptin gene therapy.
    Kalra SP
    Curr Top Med Chem; 2007; 7(17):1675-81. PubMed ID: 17979776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice.
    Begriche K; Lettéron P; Abbey-Toby A; Vadrot N; Robin MA; Bado A; Pessayre D; Fromenty B
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E939-51. PubMed ID: 18349116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergy between leptin therapy and a seemingly negligible amount of voluntary wheel running prevents progression of dietary obesity in leptin-resistant rats.
    Shapiro A; Matheny M; Zhang Y; Tümer N; Cheng KY; Rogrigues E; Zolotukhin S; Scarpace PJ
    Diabetes; 2008 Mar; 57(3):614-22. PubMed ID: 18086903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central leptin gene therapy, a substitute for insulin therapy to ameliorate hyperglycemia and hyperphagia, and promote survival in insulin-deficient diabetic mice.
    Kojima S; Asakawa A; Amitani H; Sakoguchi T; Ueno N; Inui A; Kalra SP
    Peptides; 2009 May; 30(5):962-6. PubMed ID: 19428774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptin antagonist reverses hypertension caused by leptin overexpression, but fails to normalize obesity-related hypertension.
    Tümer N; Erdös B; Matheny M; Cudykier I; Scarpace PJ
    J Hypertens; 2007 Dec; 25(12):2471-8. PubMed ID: 17984669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential of AAV vectors in the treatment of metabolic disease.
    Alexander IE; Cunningham SC; Logan GJ; Christodoulou J
    Gene Ther; 2008 Jun; 15(11):831-9. PubMed ID: 18401432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of central leptin sensitivity and energy balance in a rat model of diet-induced obesity.
    Fam BC; Morris MJ; Hansen MJ; Kebede M; Andrikopoulos S; Proietto J; Thorburn AW
    Diabetes Obes Metab; 2007 Nov; 9(6):840-52. PubMed ID: 17924866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to obesity and resistance to atherosclerosis: is there a metabolic link?
    Stein O; Stein Y
    Nutr Metab Cardiovasc Dis; 2007 Sep; 17(7):554-9. PubMed ID: 17555952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral gene therapy strategies: from basic science to clinical application.
    Young LS; Searle PF; Onion D; Mautner V
    J Pathol; 2006 Jan; 208(2):299-318. PubMed ID: 16362990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenoviral strategies for the gene therapy of cancer.
    Relph KL; Harrington KJ; Pandha H
    Semin Oncol; 2005 Dec; 32(6):573-82. PubMed ID: 16338423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptin and its metabolic interactions: an update.
    Anubhuti ; Arora S
    Diabetes Obes Metab; 2008 Nov; 10(11):973-93. PubMed ID: 18284436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments in adeno-associated virus vector technology.
    Büning H; Perabo L; Coutelle O; Quadt-Humme S; Hallek M
    J Gene Med; 2008 Jul; 10(7):717-33. PubMed ID: 18452237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy of inherited skin adhesion disorders: a critical overview.
    De Luca M; Pellegrini G; Mavilio F
    Br J Dermatol; 2009 Jul; 161(1):19-24. PubMed ID: 19466960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle and fat mass modulation in different clinical models.
    Draghia-Akli R; Khan AS
    Methods Mol Biol; 2008; 423():449-60. PubMed ID: 18370221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of leptin during perinatal metabolic programming and obesity.
    Djiane J; Attig L
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 1():55-63. PubMed ID: 18802216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.